Natriuretic peptides in cardiovascular diseases of fetus, infants and children

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 7, Issue 1, 2009, Pages 43-51

  Das, Bibhuti B ^a   Raj, Shashi ^a   Solinger, Robert ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

ANP; BNP; CNP; Natriuretic peptides; NT proBNP

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; NESIRITIDE;

CARDIOMYOPATHY; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CIRCULATION; CONGENITAL DIAPHRAGM HERNIA; CONGENITAL HEART DISEASE; CYSTIC FIBROSIS; DISEASE SEVERITY; DRUG INFUSION; DRUG SAFETY; FETUS HEART; FETUS HEART RATE; HEART DEVELOPMENT; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; KIDNEY FUNCTION; LUNG BLOOD FLOW; MONOTHERAPY; MUCOCUTANEOUS LYMPH NODE SYNDROME; ONSET AGE; ONTOGENY; PERIOPERATIVE PERIOD; PERSISTENT PULMONARY HYPERTENSION; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RESPIRATORY DISTRESS; REVIEW; TISSUE LEVEL; CARDIOVASCULAR SYSTEM; CHILD; FEMALE; FETUS; GROWTH, DEVELOPMENT AND AGING; HEART; INFANT; NEWBORN; ORGANOGENESIS; PHYSIOLOGY; PREGNANCY; PRENATAL DEVELOPMENT;

BLOOD CIRCULATION; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CHILD; FEMALE; FETUS; HEART; HUMANS; INFANT; INFANT, NEWBORN; NATRIURETIC PEPTIDES; ORGANOGENESIS; PREGNANCY;

EID: 64149131451     PISSN: 18715257     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152509787047667     Document Type: Review

References (83)

1. Das, B.B.; Solinger, R. Role of natriuretic peptide family in cardiovascular medicine. Cardiovasc. Hematol. Agents Med. Chem., 2009, 7, 29.
2. Cameron, V.A.; Ellmers, L.J. Natriuretic peptides during development of the fetal heart and circulation. Endocrinolgy, 2003, 144, 2191.
3. Cameron, V.A.; Aitken, G.D.; Ellmers, L.J.; Kennedy, M.A.; Espiner, E.A. The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology, 1996, 137, 817.
4. Gardner, D.G.; Hedges, B.K.; Wu, J.; LaPointe, M.C.; Deschepper, C.F. J. Expression of the atrial natriuretic peptide gene in human fetal heart. Clin. Endocrinol. Metab., 1989, 69, 729.
5. Zeller, R.; Bloch, K.D.; Williams, B.S.; Arceci, R.J.; Seidman, C.E. Localized expression of the atrial natriuretic factor gene during cardiac embryogenesis. Genes. Dev., 1987, 1, 693.
6. Cheung, C. Regulation of atrial natriuretic factor secretion and expression in the ovine fetus. Neurosci. Behav. Rev., 1995, 19, 159.
7. Johnson, D.; Singh, M.; Cheung, C. Effect of three hours of hypoxia on atrial natriuretic factor gene expression in the ovine fetal heart. Am. J. Obstet. Gynecol., 1997, 176, 42.
8. Rosenfield, C.R.; Samson, W.K.; Roy, T.A.; Faucher, D.J.; Magres, R.R. Vasoconstrictor-induced secretion of ANP in fetal sheep. Am. J. Physiol., 1992, 263, E 526.
9. Cheung, C. Regulation of atrial natriuretic factor release by endothelin in ovine fetuses. Am. J. Physiol., 1994, 267, R380.
10. Cao, L.; Gardner, D. Natriuretic Peptides Inhibit DNA Synthesis in Cardiac Fibroblasts. Hypertension, 1995, 25, 227.
11. John, S.W.M.; Krege, J.H.; Oliver, P.M.; Hagaman, J.R.; Hodgin, J.B.; Pang, S.C.; Flynn, T.G.; Smithies, O. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science, 1995, 267, 679.
12. Tamura, N.; Ogawa, Y.; Chusho, H.; Nakamura, K.; Nakao, K.; Suda, M.; Kasahara, M.; Hashimoto, R.; Katsuura, G.; Mukoyama, N.; Itoh, H.; Saito, Y.; Tanaka, I.; Otani, H.; Katsuki, M.; Nakao, K. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc. Natl. Acad. Sci. USA, 2000, 97, 4239.
13. Wharton, J.; Anderson, R.H.; Springall, D.; Power, R.F.; Rose, M.; Smith, A.; Espejo, R.; Khagani, A.; Wallwork, J.; Yacoub, M.H.; Polak, J.M. Localisation of atrial natriuretic peptide immunoreactivity in the ventricular myocardium and conduction system of the human fetal and adult heart. Br. Heart J., 1988, 60, 267.
14. Stepan, H.; Leitner, E.; Walter, K.; Bader, M.; Schulthesis, H.P.; Faber, R.; Walter, T. Gestational regulation of the gene expression of C-type natriuretic peptide in mouse reproductive and embryonic tissue. Regul. Pept., 2001, 102, 9.
15. Kalra, P.R.; Clague, J.R.; Bolger, A.P.; Anker, S.D.; Pool-Wilson, P.A.; Struthers, A.D.; Coats, A.J. Myocardial Production of C-Type Natriuretic Peptide in Chronic Heart Failure. Circulation, 2003, 107, 571.
16. Walter, T.; Stepan, H.; Faber, R. Dual natriuretic peptide response to volume load in the fetal circulation. Cardiovasc. Res., 2001, 49, 817.
17. Mir, T.S.; Laux, R.; Hellwege, H.H.; Liedke, B.; Heinze, C.; von Buelow, H.; Laer, S.; Weil, J. Plasma N-terminal pro-atrial-natriuretic peptide and plasma N-terminal-pro brain natriuretic peptide in healthy neonates: Marked and rapid increase after birth. Pediatrics, 2003, 112, 896.
18. Yoshibayashi, M.; Kamiya, T.; Saito, Y.; Nakao, K.; Nishioka, K.; Temma, S.; Itoh, H.; Shirakami, G.; Matsuo, H. Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. Eur. J. Endocrinol., 1995, 133, 207.
19. Nir, A.; Bar-Oz, B.; Perles, Z.; Brooks, R.; Korach, A.; Rein, A.J. N-Terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Paediatr., 2004, 93, 603.
20. Schwachtgen, L.; Herrmann, M.; Georg, T.; Schwarz, P.; Marx, N.; Lindinger, A. Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children. Z Kardiol., 2005, 94, 399.
21. Koch, A.; Singer, H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart, 2003, 89, 875.
22. Da Graca, R.L.; Hassinger, D.C.; Flynn, P.A.; Sison, C.P.; Nesin, M; Auld, P.A. Longitudinal changes of brain-type natriuretic peptide in preterm neonates. Pediatrics, 2006, 117, 2183.
23. Mir, T.S.; Flato, M; Falkenberg, J; Haddad, M; Budden, R; Weil, J; Albers, S; Laer, S. Plasma concentration of N-terminal Brain Natriuretic peptide in healthy children, adolescents and young adults: Effect of age and gender. Pediatr. Cardiol., 2006, 27, 73.
24. Reynolds, E.W.; Ellington, J.G.; Vranicar M; Bada, H.S. Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics, 2004, 114, 1297.
25. Reesink, H.J.; Tulevskim, II.; Marcus, J.T.; Boomsma, F.; Kloek, J.J.; Vonk Noordegraaf, A.; Bresser, P. Brain Natriuretic Peptide as Noninvasive Marker of the Severity of Right Ventricular Dysfunction in Chronic Thromboembolic Pulmonary Hypertension. Ann. Thorac. Surg., 2007, 84, 537.
26. Leuchte, H.H.; Holzapfel, M.; Baumgartner, R.A.; Ding, I.; Neurohr, C.; Vogeser, M.; Kolbe, T.; Schwaiblmair, M.; Behr, J. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. Am. Coll. Cardiol., 2004, 43, 764.
27. Ben Tov, A.; Paret, G.; Sela, B.A.; Balu, H.; Hegesh, J.; Efratio, O.; Yahar, Y.; Augarten, A. N-terminal pro B-type natriuretic peptide (N-BNP) levels in cystic fibrosis patients. Pediatr. Pulmonol., 2007, 42, 699.
28. Baptisa, M.J.; Noqueira-Silva, C.; Areias, J.C.; Correia-Pinto, J. Perinatal profile of ventricular overload markers in congenital diaphragmatic hernia. J. Pediatr. Surg., 2008, 43, 627.
29. Nagaya, N.; Nishikimi, T.; Uematsu, M.; Satoh, T.; Kyotani, S.; Sakamaki, F.; Kakishita, M.; Fukushima, K.; Okano, Y.; Nakanishi, N.; Miyatake, K.; Kangawa, K. Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension. Circulation, 2000, 102, 865.
30. Yanagisawa, A.; Yokota, N.; Miyagawa, M.; Kawamura, J.; Ishihara, T.; Aoyagi, T.; Ishikawa, K. Plasma levels of atrial natriuretic peptide in patients with Duchenne's progressive muscular dystrophy. Am. Heart J., 1990, 120, 1154.
31. Koch, A.; Zink, S.; Singer, H. B-type natriuretic peptide in pediatric patients with congenital heart disease. Eur. Heart J., 2006, 27, 861.
32. Toyono, M.; Harade, K.; Tamura, M.; Aoki-Okazaki, M.; Shimada, S.; Yamada, J.; Takada, G. Paradoxical relationship between B-type natriuretic peptide and pulmonary vascular resistance in patients with ventricular septal defect and concomitant severe pulmonary hypertension. Pediatr. Cardiol., 2008, 29, 65.
33. Suda, K.; Matsumura, M.; Matsumoto, M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr. Int., 2003, 45, 249.
34. Choi, B.M.; Lee, K.H.; Eun, B.L.; Yoo, K.H.; Hong, Y.S.; Son, C.S.; Lee, J.W. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics., 2005, 115, e255.
35. Sangeev, S.; Pettersen, M.; Lua, J.; Thomas, S.; Shankaran, S.; L'Ecuyer, T. Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates. J. Perinatol., 2005, 25, 709.
36. Mir, T.S.; Falkenberg, J.; Friedrich, B.; Gottschalk, U.; Phi Lê, T.; Laer, S.; Weil, J. Levels of brain natriuretic peptide in children with right ventricular overload due to congenital cardiac disease. Cardiol. Young, 2005, 15, 396.
37. Flynn, P.A.; Da Graca, R.L.; Auld, P.A.M.; Nesin, M.; Kleinman, C.S. The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J. Pediatr., 2005, 147, 38.
38. Holmstrom, H.; Hall, C.; Thaulow, E. Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr., 2001, 90, 184.
39. Kadar, K.; Nagy, E.; Gal, K.; Oprea, V.; Hartyanszky, I.; Gyarmati, G.; Toth, A.; Sikos, Z. Utility of B-type natriuretic peptide in children. Orv. Hetil., 2007, 148, 265.
40. Koch, A.; Kitzsteiner, T.; Zink, S.; Cesnjevar, R.; Singer, H. Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease. Int. J. Cardiol., 2007, 114, 339.
41. Kaski, J.P.; Tome-Esteban, M.T.; Mead-Regan, S.J.; Pantazis, A.; Mark, J.; Deanfield, J.E.; McKenna, W.J.; Elliott, P.M. B-Type Natriuretic Peptide Predicts Disease Severity in Children With Hypertrophic Cardiomyopathy. Heart, 2007, 94(10), 1307-11.
42. Price, J.F.; Thomas, A.K.; Grenier, M.; Eidem, B.W.; O'Brian Smith, E.; Denfield, S.W.; Towbin, J.A.; Dreyer, W.J. B-Type Natriuretic Peptide Predicts Adverse Cardiovascular Events in Pediatric Outpatients With Chronic Left Ventricular Systolic Dysfunction. Circulation, 2006, 114, 1063.
43. Westerlind, A.; Wahlander, H.; Lindstedt, G.; Lundberg, P.A.; Holmgren, D. Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr., 2004, 93, 340.
44. Ekstein, S.; Nir, A.; Rein, A.J.; Perles, Z.; Bar-Oz, B.; Salpeter, L.; Alqur, N.; Weintraaub, M. N-Terminal-proB-Type Natriuretic Peptide as a Marker for Acute Anthracycline Cardiotoxicity in Children. J. Pediatr. Hematol. Oncol., 2007, 29, 440.
45. Germanakis, I.; Kalmanti, M.; Parthenakis, F.; Nikitovic, D.; Stiakaki, E.; Patrianakos, A.; Vardas, P.E. Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines. Int. J. Cardiol., 2006, 108, 212.
46. Babuin, L.; Algeria, R.J.; Oh, J.K.; Nishimura, R.A.; Jaffe, A.S. Brain Natriuretic Peptide Levels in Constrictive Pericarditis and Restrictive Cardiomyopathy. J. Am. Coll. Cardiol., 2006, 47, 1489.
47. Kawamura, T.; Wago, M.; Kawaguchi, H.; Tahara, M.; Yuge, M. Plasma brain natriuretic peptide concentrations in patients with Kawasaki disease. Pediatr. Int., 2000, 42, 241.
48. Takeuchi, D.; Saji, T.; Takatsuki, S.; Fujiwara, M. Abnormal tissue doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease. Circ. J., 2007, 71, 357.
49. Kawamura, T.; Wago, M. Brain natriuretic peptide can be a useful biochemical marker for myocarditis in patients with Kawasaki disease. Cardiol. Young, 2002, 12, 153.
50. Kurotobi, S.; Kawakami, N.; Shimizu, K.; Apki, H.; Nasuno, S.; Takashashi, K.; Kogaki, S.; Ozono, K. Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki disease. Pedaitr. Cardiol., 2005, 26, 425.
51. Cohen, S.; Springer, C.; Avital, A.; Perles, Z.; Rein, A.J.; Argaman, Z.; Nir, A. Amino-terminal pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress?. Pediatrics, 2005, 115, 1347.
52. Koulouri, S.; Acherman, R.J.; Wong, P.C.; Chan, L.S.; Lewis, A.B. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr. Cardiol., 2004, 25, 341.
53. Burnett, J.C., Jr.; Kao, P.C.; Hu, D.C.; Heser, D.W.; Heublein, D.; Granger, J.P.; Opgenorth, T.J.; Reeder, G.S. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science, 1986, 231, 1145.
54. Raine, A.E.; Erne, P.; Burgisser, E.; Muller, F.B.; Bolli, P.; Burkart, F.; Buhler, F.R. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N. Engl. J. Med., 1986, 315, 533.
55. Richards, A.M.; Crozier, I.G.; Espiner, E.A.; Yandle, T.G.; Nicholls, M.G. Plasma brain natriuretic peptide and endopeptidase 24.11 inhibition in hypertension. Hypertension, 1993, 22, 231.
56. Richards, A.M.; Cleland, J.F.; Tonolo, G.; McIntyre, G.D.; Leckie, B.J.; Dargie, H..J; Ball, S.G.; Robertson, J.I. Plasma alpha natriuretic peptide in cardiac impairment. Br. Med. J. (Clin. Res. Ed.), 1986, 293, 409.
57. Hensen, J.; Abraham, W.T.; Lesnefsky, E.J.; Levenson, B.; Groves, B.M.; Schroder, K.; Schrier, R.W.; Durr, J. Atrial natriuretic peptide kinetic studies in patients with cardiac dysfunction. Kidney, 1992, 41, 1333.
58. Poulos, J.E.; Gower, Jr., W.R.; Sullebarger, J.T.; Fontanet, H.L.; Vesely, D.L. Atrial natriuretic peptide kinetic studies in patients with cardiac dysfunction. Cardiovasc. Res., 1996, 32, 909.
59. Nir, A.; Bar-Oz, B.; Perles, Z.; Brooks, R.; Korach, A.; Rein, A.J. N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases. Acta Pediatr., 2004, 93, 603.
60. Fried, I.; Bar-Oz, B.; Perles, Z.; Rein, A.J.; Zonis, Z.; Nir, A. N-terminal pro-B-type natriuretic peptide levels in acute versus chronic left ventricular dysfunction. J. Pediatr., 2006, 149, 28.
61. Mir, T.S.; Marohn, S.; Laer, S.; Eiselt, M.; Grollmus, O.; Weil, J. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics, 2002, 110, e76.
62. Ootaki, Y.; Yamaguchi, M.; Yoshimura, N.; Oka, S.; Yoshida, M.; Hasegawa, T. Secretion of A-type and B-type natriuretic peptides into the bloodstream and pericardial space in children with congenital heart disease. J. Thorac. Cardiovasc. Surg., 2003, 126, 1411.
63. Murdoch, D.R.; McDonagh, T.A.; Byrne, J.; Blue, L.; Farmer, R.; Morton, J.J.; Dargie, H.J. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am. Heart J., 1999, 138, 1126.
64. Yasue, H.; Yoshimura, M.; Sumida, H.; Kikuta, K.; Kugiyama, K.; Jougasaki, M.; Ogawa, H.; Okumura, K.; Mukoyama, M.; Nakao, K. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation, 1994, 90, 195.
65. Park, M.H.; Scott, R.L.; Uber, P.A.; Harris, B.C.; Chambers, R; Mehra, M.R. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function. Am. J. Cardiol., 2002, 90, 1326.
66. Mehra, M.R.; Uber, P.A.; Walther, D.; Vesely, M.; Wohlgemuth, J.G.; Prentice, J.; Tayama, D.; Billingham, M. Gene Expression Profiles and B-Type Natriuretic Peptide Elevation in Heart Transplantation: More Than a Hemodynamic Marker. Circulation, 2006, 114(Suppl. I), 21.
67. Geny, B.; Charloux, A.; Brandenberger, G.; Piquard, F. Despite cardiac denervation, atrial natriuretic peptides possess a cardiac sympathoinhibitory effect after heart transplantation. J. Thorac. Cardiovasc. Surg., 2006, 131, 1417.
68. Mehra, M.R.; Uber, P.A.; Potluri, S.; Ventura, H.O.; Scott, R.L.; Park, M.H. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation. Am. J. Cardiol., 2004, 94, 454.
69. Gardner, R.S.; Chong, K.S.; Murday, A.J.; Morton, J.J.; McDonagh, T.A. N-terminal brain natriuretic peptide is predictive of death after cardiac transplantation. Heart, 2006, 92, 121.
70. Ambrosi, P.; Oddoze, C.; Ribéri, A.; Arques, S.; Portugal, H.; Métras, D.; Habib, G. Usefulness of N-terminal-pro-brain natriuretic peptide levels in predicting survival in heart transplant recipients. Am. J. Cardiol., 2004, 94, 1585.
71. Walsh, R.; Boyer, C.; LaCorte, J.; Parnell, V.; Sison, C.; Chowdhury, D.; Ojamaa, K. N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery. J. Thorac. Cardiovasc. Surg., 2008, 135, 98.
72. Mainwaring, R.D.; Parise, C.; Wright, S.B.; Juris, A.L.; Achtel, R.A.; Fallah, H. Brain Natriuretic Peptide Levels Before and After Ventricular Septal Defect Repair. Ann. Thorac. Surg., 2007, 84, 2066.
73. Koch, A.; Kitzsteiner, T.; Zink, S.; Cesnjevar, R.; Singer, H. Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease. Int. J. Cardiol., 2007, 114, 339.
74. Lechner, E.; Gitter, R.; Mair, R.; Pintu, M.; Schreier-Lechner, E.; Vondrys, D.; Talzer, G. Aminoterminal brain natriuretic Peptide levels in children and adolescents after fontan operation correlate with congestive heart failure. Pediatr. Cardiol., 2008, 29, 901.
75. Hsu, J.H.; Oishi, P.E.; Kella, R.L.; Chikovani, O.; Karl, T.R.; Azakie, A.; Adatia, I.; Fineman, J.R. Perioperative B-type natriuretic peptide levels predict outcome after bidirectional cavopulmonary anastomosis and total cavopulmonary connection. J. Thorac. Cardiovasc. Surg., 2008, 135, 746.
76. D'Souza, S.P.; Baxter, G.F. B Type natriuretic peptide: a good omen in myocardial ischaemia? Heart, 2003, 89, 707.
77. Rosenkranz, A.C.; Woods, R.L.; Dusting, G.J.; Ritchie, R.H. Anti-hypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP. Cardiovasc. Res., 2003, 57, 515.
78. Knowles, J.W.; Esposito, G.; Mao, L.; Hagaman, J.R.; Fox, J.E.; Smithies, O.; Rockman, H.A.; Maeda, N. Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J. Clin. Invest., 2001, 107, 975.
79. Cao, L.; Gardner, D. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension, 1995, 25, 227.
80. Tamura, N.; Ogawa, Y.; Chusho, H.; Nakamura, K.; Nakao, K.; Suda, M.; Kasahara, M.; Hashimoto, R.; Katsuura, G.; Mukoyama, M. Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc. Natl. Acad. Sci. USA, 2000, 97, 4239.
81. Feingold, B.; Law, Y.M. Nesiritide use in pediatric patients with congestive heart failure. J. Heart Lung Transplant., 2004, 23, 1455.
82. Marshall, J.; Berkenbosch, J.W.; Russo, P.; Tobias, J.D. Preliminary Experience With Nesiritide in the Pediatric Population. J. Intensive Care Med., 2004, 19, 164.
83. Jefferies, J.L.; Price, J.F.; Denfield, S.W.; Chang, A.C.; Dreyer, W.J.; McMahon, C.J.; Grenier, M.A.; Clunie, S.K.; Thomas, A.; Moffett, B.S.; Wann, T.S.; Smith, E.O.; Towbin, J.A. Safety and efficacy of nesiritide in pediatric heart failure. J. Card. Fail., 2007, 13S, 541.